Generic placeholder image

Current Clinical Pharmacology

Editor-in-Chief

ISSN (Print): 1574-8847
ISSN (Online): 2212-3938

Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies

Author(s): Thorvardur R. Halfdanarson and Jonathan R. Strosberg

Volume 10, Issue 4, 2015

Page: [305 - 310] Pages: 6

DOI: 10.2174/1574884710666151020100211

Price: $65

Abstract

Neuroendocrine tumors (NETs) are relatively uncommon. They typically arise in the gastrointestinal tract and lungs, and their incidence seems to be rising. Most patients have advanced disease at the time of diagnosis and many more will relapse after surgery. There is thus a great need for improvements in therapy for advanced neuroendocrine tumors. This article reviews the current therapy for both pancreatic NETs and non-pancreatic gastrointestinal NETs, and discusses recent advances in NET management with an emphasis on targeted therapy.

Keywords: Carcinoid tumors, neuroendocrine tumors, targeted therapy, therapy.


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy